The Renovatio team is responsible for managing the daily clinical research conduct and operations at its business associates’ sites. All work is done under the principal investigator’s supervision and oversight as defined per the Good Clinical Practices guidelines and federal regulations.

Executive & Clinical Leadership

Talal A. Kayyal, MD, MPH

Founder & Chief Executive Officer

Mary K. Crow, MD

Principal Investigator
Hematology & Oncology

Ather J. Siddiqi, MD

Principal Investigator
Pulmonary Medicine

Drew A. Dylewski, MD

Principal Investigator
Urology

Mahran Shoukier, MD

Principal Investigator
Hematology & Oncology

Advisory Board

Wael Asi, MD

Privia Health

Mary Crow, MD

Renovatio Medical

Michaele Linden-Johnson, FACHE, MBA, LCSW

Medical Center of the Americas Foundation

Christine Capitan, MBA

The University of Texas MD Anderson Cancer Center

Walid Naddaf, M.Pet.E.

Chevron